Literature DB >> 22157096

A role for sister telomere cohesion in telomere elongation by telomerase.

Benjamin R Houghtaling1, Silvia Canudas, Susan Smith.   

Abstract

Telomere length homeostasis is achieved by a balance of telomere shortening caused by DNA replication and nucleolytic attack and telomere lengthening by telomerase. The importance of telomere length maintenance to human health is best illustrated by dyskeratosis congenita (DC) a disease of telomere shortening caused by mutations in telomerase subunits. DC patients suffer stem cell depletion and die of bone marrow stem cell failure. Recently a new class of particularly severe DC patients was found to harbor mutations in the shelterin subunit TIN2. The DC-TIN2 mutations were clustered in small domain of unknown function. In a recently published study we showed that the DC mutation cluster in TIN2 harbored a binding site for heterochromatin protein 1 (HP1) and further, that HP1 binding to TIN2 was required for sister telomere cohesion in S phase and for telomere length maintenance by telomerase. We briefly review and discuss the implications of our findings in this Extra View, and present some new data that may shed light on how sister telomere cohesion could influence telomere elongation by telomerase.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157096      PMCID: PMC3272229          DOI: 10.4161/cc.11.1.18633

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  64 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2.

Authors:  D Broccoli; A Smogorzewska; L Chong; T de Lange
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Telomeric localization of TRF2, a novel human telobox protein.

Authors:  T Bilaud; C Brun; K Ancelin; C E Koering; T Laroche; E Gilson
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 5.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

6.  The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chromo domain dimer.

Authors:  S V Brasher; B O Smith; R H Fogh; D Nietlispach; A Thiru; P R Nielsen; R W Broadhurst; L J Ball; N V Murzina; E D Laue
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

7.  The HP1 chromo shadow domain binds a consensus peptide pentamer.

Authors:  J F Smothers; S Henikoff
Journal:  Curr Biol       Date:  2000-01-13       Impact factor: 10.834

8.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Functionally interacting telomerase RNAs in the yeast telomerase complex.

Authors:  J Prescott; E H Blackburn
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

10.  Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.

Authors:  S Smith; I Giriat; A Schmitt; T de Lange
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

View more
  11 in total

1.  Inter-telomeric recombination is present in telomerase-positive human cells.

Authors:  Margit Dlaska; Patrick Schöffski; Oliver E Bechter
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

2.  Age-related response to an acute innate immune challenge in mice: proteomics reveals a telomere maintenance-related cost.

Authors:  François Criscuolo; Gabriele Sorci; Margaux Behaim-Delarbre; Sandrine Zahn; Bruno Faivre; Fabrice Bertile
Journal:  Proc Biol Sci       Date:  2018-12-05       Impact factor: 5.349

3.  Cell cycle-regulated ubiquitination of tankyrase 1 by RNF8 and ABRO1/BRCC36 controls the timing of sister telomere resolution.

Authors:  Ekta Tripathi; Susan Smith
Journal:  EMBO J       Date:  2016-12-19       Impact factor: 11.598

4.  BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.

Authors:  Shu Wu; Yuanlong Ge; Laiqiang Huang; Haiying Liu; Yong Xue; Yong Zhao
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 5.  Molecular basis of telomere dysfunction in human genetic diseases.

Authors:  Grzegorz Sarek; Paulina Marzec; Pol Margalef; Simon J Boulton
Journal:  Nat Struct Mol Biol       Date:  2015-11       Impact factor: 15.369

6.  Telomeres and viruses: common themes of genome maintenance.

Authors:  Zhong Deng; Zhuo Wang; Paul M Lieberman
Journal:  Front Oncol       Date:  2012-12-31       Impact factor: 6.244

Review 7.  Finding the end: recruitment of telomerase to telomeres.

Authors:  Jayakrishnan Nandakumar; Thomas R Cech
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-09       Impact factor: 113.915

Review 8.  Telomere length reprogramming in embryos and stem cells.

Authors:  Keri Kalmbach; LeRoy G Robinson; Fang Wang; Lin Liu; David Keefe
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

9.  One identity or more for telomeres?

Authors:  Marie-Josèphe Giraud-Panis; Sabrina Pisano; Delphine Benarroch-Popivker; Bei Pei; Marie-Hélène Le Du; Eric Gilson
Journal:  Front Oncol       Date:  2013-03-15       Impact factor: 6.244

Review 10.  Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.

Authors:  Maria M Gramatges; Alison A Bertuch
Journal:  Transl Res       Date:  2013-06-01       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.